Skip to main content

Advertisement

Table 1 Clinical characteristics (n = 63)

From: Testing the effects of gentle vibrotactile stimulation on symptom relief in fibromyalgia

Age, years, mean (SD) 53.7 (8.1)
Sex, females, n (%) 63 (100)
Height, cm, mean (SD) 161 (6)
Weight, kg, mean (SD) 69.2 (13.6)
Hand-dominance, n (%) right-handers 56 (89)
Education level, years, mean (SD) 14.1 (3.9)
Illness duration, mean (SD), years since diagnosis 7.7 (5.8)
Fibromyalgia Impact Questionnaire*, mean (SD) 63.6 (15.1)
General perception of health**, mean (SD) 33.1 (17.6)
Hospital Anxiety and Depression Scale (HADS)
 Anxiety, mean (SD) 11.2 (4.1)
 Depression, mean (SD) 9.8 (4.4)
Stable medication regime
 NSAIDs, n (%) 29 (46)
 Opioids (tramadol), n (%) 24 (38)
 Paracetamol, n (%) 34 (54)
 Gabapentin, n (%) 25 (40)
 Antidepressants
  SSRI, n (%) 18 (29)
  SNRI, n (%) 20 (32)
  Others, n (%) 14 (22)
 Anxiolytics/hypnotics (benzodiazepines), n (%) 42 (67)
  1. *Fibromyalgia Impact Questionnaire (FIQ), maximum score, 100. **According to the 36-Item Short-Form Health Survey, maximum score, 100. Several patients were taking more than one medication. NSAIDs non-steroidal anti-inflammatory drugs, SSRI selective serotonin reuptake inhibitor, SNRI serotonin-norepinephrine reuptake inhibitor